Categories
Change Password!
Reset Password!
COVID-19 sharply increases mortality risk in CKD patients with obesity, heart disease, or diabetes—highlighting an urgent need for targeted care strategies.
A recent study highlighted the intricate link between COVID-19 and increased mortality among those with chronic kidney disease (CKD), particularly those with underlying conditions such as ischemic coronary disease, obesity, and diabetes.
The SARS-CoV-2 virus, which belongs to the Coronaviridae family, is responsible for COVID-19, a disease that frequently results in serious respiratory issues akin to those caused by Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). The World Health Organization announced COVID-19 as a worldwide epidemic on March 11, 2020. The first confirmed case occurred on February 26, 2020, in Romania, marking the start of momentous challenges that affected countless lives.
The COVID-19 pandemic has particularly impacted individuals with kidney issues, as patients with renal impairment are at an elevated risk for severe outcomes from SARS-CoV-2 infection, including higher mortality rates. CKD is associated with significant immunocompromising effects, which increase the likelihood of contracting the virus and result in higher rates of hospitalization, oxygen therapy, and extended treatment periods.
However, the management of CKD patients receiving renal replacement therapy (RRT) during SARS-CoV-2 infection remains ambiguous. These patients often contend with multiple comorbidities, including cardiovascular conditions such as hypertension and left ventricular hypertrophy, as well as diabetes. A crucial question arises regarding whether RRT contributes to poorer outcomes for those infected with SARS-CoV-2, especially since infections frequently lead to severe complications in this population.
This retrospective study by Ileana Adela Vacaroiu et al. investigated the progression of COVID-19 in CKD patients, particularly examining the interplay with prevalent comorbidities like ischemic coronary disease, obesity, and diabetes. The analysis included 72 hemodialysis patients hospitalized at the Department of Nephrology and Dialysis, "Sf. Ioan" Clinical Emergency Hospital, Bucharest, Romania, while excluding those undergoing peritoneal dialysis.
The findings indicate that older age is a significant risk factor for mortality among hemodialyzed patients hospitalized with COVID-19, with obesity further heightening the risk of death in this vulnerable group.
Cureus
Long-Term Interplay Between SARS-CoV-2 and Renal Impairment
Ileana Adela Vacaroiu et al.
Comments (0)